Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaning Yang

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Thoracic Cancer|October 19, 2020
Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIsLu Yang, Xuezhi Hao, Xingsheng Hu, et al.
Cancer Medicine|May 24, 2022
First-line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 insertions: Real-world evidence from ChinaGuangjian Yang, Yaning Yang, Runze Liu, et al.
Journal of Gastroenterology and Hepatology|October 1, 2008
Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinomaCheng Wu, Zhanfeng Wang, Lijie Liu, et al.
Journal of the National Cancer Center|July 22, 2024
Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)Guangjian Yang, Xuezhi Hao, Jiaqi Hu, et al.
Nucleic Acids Research|February 19, 2019
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studiesYi Han, Juze Yang, Xinyi Qian, et al.
Thoracic Cancer|October 11, 2022
Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practiceYaning Yang, Xin Ai, Haiyan Xu, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i>-altered NSCLC: a retrospective real-world POLISH studyGuangjian Yang, Yaning Yang, Runze Liu, et al.
Environmental Science & Technology|January 28, 2010
Influence of coal-tar sealcoat and other carbonaceous materials on polycyclic aromatic hydrocarbon loading in an urban watershedYaning Yang, Peter C Van Metre, Barbara J Mahler, et al.
BMC Medicine|May 13, 2022
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Nucleic Acids Research|March 21, 2021
Corrigendum to article "DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies''Yi Han, Juze Yang, Xinyi Qian, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Thoracic Cancer|October 19, 2020
Superior efficacy of immunotherapy-based combinations over monotherapy for EGFR-mutant non-small cell lung cancer acquired resistance to EGFR-TKIsLu Yang, Xuezhi Hao, Xingsheng Hu, et al.
Cancer Medicine|May 24, 2022
First-line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non-small cell lung cancer with EGFR exon 20 insertions: Real-world evidence from ChinaGuangjian Yang, Yaning Yang, Runze Liu, et al.
Journal of Gastroenterology and Hepatology|October 1, 2008
Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinomaCheng Wu, Zhanfeng Wang, Lijie Liu, et al.
Journal of the National Cancer Center|July 22, 2024
Pyrotinib in HER2 heterogeneously mutated or amplified advanced non-small cell lung cancer patients: a retrospective real-world study (PEARL)Guangjian Yang, Xuezhi Hao, Jiaqi Hu, et al.
Nucleic Acids Research|February 19, 2019
DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studiesYi Han, Juze Yang, Xinyi Qian, et al.
Thoracic Cancer|October 11, 2022
Treatment patterns and outcomes of immunotherapy in extensive-stage small-cell lung cancer based on real-world practiceYaning Yang, Xin Ai, Haiyan Xu, et al.
Therapeutic Advances in Medical Oncology|March 7, 2022
First-line immunotherapy or angiogenesis inhibitor plus chemotherapy for <i>HER2</i>-altered NSCLC: a retrospective real-world POLISH studyGuangjian Yang, Yaning Yang, Runze Liu, et al.
Environmental Science & Technology|January 28, 2010
Influence of coal-tar sealcoat and other carbonaceous materials on polycyclic aromatic hydrocarbon loading in an urban watershedYaning Yang, Peter C Van Metre, Barbara J Mahler, et al.
BMC Medicine|May 13, 2022
Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancerChengming Liu, Lu Yang, Haiyan Xu, et al.
Nucleic Acids Research|March 21, 2021
Corrigendum to article "DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies''Yi Han, Juze Yang, Xinyi Qian, et al.
Pageof 14